Renzenbrink & Partner advises Deutsche Intensivpflege Holding on the acquisition of Linde Remeo Deutschland GmbH

7 May 2018

Deutsche Intensivpflege Holding B.V. (DIH) has acquired Linde Remeo
Deutschland GmbH (Remeo) by way of a structured auction process. The
acquisition is still subject to clearance by the German Federal Cartel Office.
Remeo forms part of the healthcare division of the Linde Group and offers
medium- and long-term care for respiratory patients with subacute and chronic
conditions. With its innovative concept for long-term ventilated patients, Remeo
closes the gap between intensive inpatient respiratory treatment and a return to
the home environment. Remeo has approximately 200 employees at its seven
locations across Germany.

Founded in 2013, DIH is one of the largest outpatient intensive care groups in
Germany and currently cares for approximately 550 patients in need of intensive
care nationwide. With more than 2,500 employees, DIH now provides care for
children and adults both in one-on-one care and in more than 60 residential care
communities. In recent years, the company has acquired specialized expertise in
the field of intensive care for children.

In November 2016, Renzenbrink & Partner advised Ergon Capital Partners on the
acquisition of a majority stake in DIH. As part of its growth strategy, DIH has
since subsequently acquired numerous outpatient care providers throughout
Germany. Renzenbrink & Partner has advised DIH on all legal aspects (including
integration measures) of such transactions.

For the acquisition of Linde Remeo Deutschland, the Renzenbrink & Partner team
consisted of Dr Dennis Schlottmann (transaction lead), Dr Ulf Renzenbrink
(both Corporate/M&A) and Marc H. Kotyrba (Tax) as well as associate Dr
Alexander Haunschild (Corporate/M&A).